SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-13-000015
Filing Date
2013-05-13
Accepted
2013-05-13 17:22:58
Documents
10
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q abio-10q_20130331.htm 10-Q 1385381
2 EX-31.1 abio-ex31_2013033039.htm EX-31 9594
3 EX-31.2 abio-ex31_2013033040.htm EX-31 9433
4 EX-32.1 abio-ex32_2013033041.htm EX-32 14874
  Complete submission text file 0001564590-13-000015.txt   5320684

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT abio-20130331.xml EX-101.INS 558684
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abio-20130331_pre.xml EX-101.PRE 261772
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abio-20130331_lab.xml EX-101.LAB 309738
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE abio-20130331_def.xml EX-101.DEF 223488
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE abio-20130331_cal.xml EX-101.CAL 39751
10 XBRL TAXONOMY EXTENSION SCHEMA abio-20130331.xsd EX-101.SCH 44457
Mailing Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-22873 | Film No.: 13838441
SIC: 2835 In Vitro & In Vivo Diagnostic Substances